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Timely admbdslralian of verapamil has been shown In 
reduce indexes ofiwhemic injury in ex$rrimentat modrlsof 
pratongrd cornnary s*ry ocPt”lto”, yet t,s act on COW 
tracfite fuorti~ of reversibly injured (Ihat is, “slumed”) 
myacardium remains unknown. The nbjeclive of the 
prfwt study was to determine whether verapnmt&ad. 
ministered either 30 mto hefore coronary artery ocx?lusk~%~ 
at the Bme of rwerf&m or 30 min after rernrfusiow 
by 15 min of transient roronwy artery occk~sion in snw 
thelined, upen chosl dogs. 
AJ treatmen, groups exhibited passive systolic bulging 
durina cetusion. In (be conlrol dws recrivtne Jaltnr solw 
lion. &men, shortening in ,he pr&sly i&h&c ttsme 
awaged only 31 * 6% ofnmnut baseline values tdler 3 b 
oi reperfuston. In addition, rndorardial @denmine trlpbw 
phdce tATI? ~mrn were doploted by -8.7 * 0.8 nmoVmg 
eardisc protein !o 26.5 I 1.1 m,,oVma pm,&,, and andc. 
cardial crplline phosphate wnlen, Increased by 9.6 t 4.3 
nmotlmg wdttc pratetn over normal vatue9. Pretreatment 
wtlh wrapemil ewntialty ablat& the phsnomemm of pal- 
tscbemic stwlnt”~: za?nlen, Ehorteninn was reslored to 115 
f 8% OF no&, a&r 3 h of ret?& (p < 0.0, venw 
controt). :ndoardiat ATP store were ~m’ttall~ !mserwd 
(30.6 t 1.2 nmokg protein; p < 0.05 WRUS c&rot) and 
crestina pbmphale overshwt was blunted (endcardiat 
cnatine ohombate content decreased by -5.6 f 2.9 
nmollmg &in; p < 0.05 venns control): 
VerapmU adminIstered a, or after rep&u&m atso 
attenualed fastischemic anlractitr dysfunctbn: sfgognr~nt 
shortentng ior both groups recovered to 63 f 9% oi 
bsutbtr a,, 3 b after qxrfusion (p < 0.05 verws controt,. 
Vwaprmil given at or a&r reprfusion had no knrtiat 
etfect, howewz, an high energy phwpbab %res. Thus, 
ewn wbrn trentment was “delmyed.” that is, initiated at or 
ntkr repertbdoo, admtnislntloo ol venpamtt signiecantty 
i!.ilwed amlratlik fundfon of the pmttxbmic stmmd 
lll~KZdi”lll. 
Postischemic myocardiat “srunning.” or depressed contrac- 
tile function and abnormal high energy phosphate met&- 
lism in the absence of myocyte necrosis, has been cxten- 
sively documented in experimental models ofbrief, transient 
periods of coronary aflay occlusion followed by retwIuusion 
(I-4). More recently, the phenomenon of the stonncd rnyo. 
cardium has been ,dentified after clinical instances of b&f, 
transient irchemia induced by exercise (5) or by coronary 
angtoplasty (61 and in patients having undergone reperfusion 
for the ,reatment of acute myocardial infarction (7). A 
pharmacologic agent that would safely improve contractile 
function of stunned myocardium (that is, without increasing 
mvocardial oween demand) would be of ootential clinical 
b&tit. .- 
Timely administration of the calcium channel blocking 
agent verapamil has been shown by many investigators 
(8-19) Lo reduce indexes of ischemic injury in models of 
prolonged coronary artery occlusion resulting in myocytc 
necrosis. Does verapdmil treatment also have a beneficial 
effect on revrrsihly injured. stunned myocardium? The ob- 
jective of the present study was to determine whether 
verspamil-administered either before coronary arlery OP 
ctusion. at the time of reperfusion or well atIer reflow had 
been established-could aLlenWe contractile dysfunction 
and enhance high energy phosphate store, in a canine madei 
of the povischemic stunned myocardium. 
Methods 14 mm of coronary occlusion. Veravamd admmistraticn 
&xper;Gen:a! preper2!inn. F”rtv_elphl mongrel dogs or 
A small regmenr of the /eJ! anterior descending cnronn~ 
either SEX, weighing an average of 22.4 * 4.2 kg. were 
artery was dissected free of sun‘ounding tissue and isolated. 
anesthetized with an intravcnow mjectmn of codium pemo- 
barbital (30 mdkg body weight). intubated and ventilated 
with room air. After cannulation of the left external iunder 
vein (for administration of drugs and fluids1 and [hi left 
common carotid anery (for measurement of heart rate and 
arterial pressuren~, a left thoracoromy was performed 
through the fifth intercostal space. The ribs were retracted. 
the parietal pericardium was incised and the cut edgec were 
sutured to the chest wall to support the heart in a pericardial 
cradle. The left atrium was then cannulated for wbsequent 
ittjectior. of radioactive microspheres for measurement of 
regional myocardial blood Row. and a Millar microtippped 
pressure transducer was positioned wrhm the left vertncular 
cavity through the left atrial appendage for measurement of 
left ventricular pressure and its first deriva!ive. dP/dt. 
,umc doie x that in Group II was then initiated tmmedi- 
~!riv hvJow rrrxrfilcion, and maintained for the remainder 
of the cxpenme”,. 
Group 3. Vernpamil efleler reperfision: saline rolution (1 
mllmm) infused 30 min before occlusion, during coronary 
occlwon and the initial 30 min of reperfusion. Vcmpamil 
admmistratwn (same dox a~ in Groups I and 2) was then 
begun at 30 mm after reperfusion and maintamed for the final 
150 ml” of rctlow. 
Grnnp 4. Conwol: saline solution (I mUmint infused 30 
min preocclusion and maintained throughout coronary oc- 
clwion and reperfunion. 
It should be noted that the firs1 20 dogs entered into the 
study wre randomized into Groups I. 3 or 1: Group 2 
,verapamd at reperfusion) was added et this point and the 
gional contractile function after the 30 min~“pretreatment” 
final 28 dogs were randomized among all iour treatment 
oeriod with ver;~oamillwline infusion. each doe received a 
PT”ll”C. q.--r 
Procedures. APer assessment of hemodvnamics and re- 
usuelly just distal to its fits1 major diagonal branch. The 
artery was then briefly occluded for cS s to delineate the 
boles dose of lidwaine (I.5 &kg). The left -anterior de- 
scending coronnty anery ~8s then abruptly occluded using 
extent of cyanosis. Schwartz atrwimatic vascular clamps. Measurements of 
Regional conrrocrile Junction in both rhe soon IO be hemodynamxs end regional contractile ftinction were ob- 
isckemic tissue and nonn& per.&red myocordiam WI 
assessed by sonomicmmel~, the details of which have been 
presented previously (4.20). One pair of ubrasonic crystals. 
used to measure segment shortening. was inserted by means 
of small scalpel inctsions into the midmyocardium m the 
center of the left anterior descending coronary artery bed at 
a separation of 6 to 12 mm and oriented parallel to the minor 
axis of the heart. A second pair of crystals was similarly 
positioned within the territory of the normally perfused 
circumflex coronary artery, et a site remote from the margin 
of the soa to be ischemic bed. Segment shortening in both 
nomtal and ischemic myocardium. arterial and left ventticu- 
lar oressures. and dP/dt were monitored continuouslv 
tamed at 5 min after a&ion. and radioactive mlcrocpheres 
for meawrement of reeional mvoardial blood Row were 
mjected at IO min aft& occlusion. Fifteen minutes aRcr 
occlusion. a wpplemental lidocaine bolus was administered 
(0.75 “@kg) iand the artery war rep&used by abrupt re- 
moval of the wxutar clamps. Hemodynamic~ end regional 
contractile fenction were monitored et I5 mio intervals 
throughout reprfusian. and at 2 h after reperfueion an 
additional blood Row measurement was obtained. 
lmmedia!ely before rht dogs were killed CC 3 h afrer 
rrprrJusion. trensmural needle biopsy specimens were ob- 
tained from both the previously ischemic and the remote. 
normallv perfused mvocardium, divided into endocardial 
throighout each experiment on a Gould recorder. and epi&dial hal&and assayed for adenosine triphos- 
Pmtwd. AIter initial baseline measurement of regional phate and creatine phosphate content IZb22). The left 
contractile function and hemodynamic variables. each dog anterior descending coronary artery was then reoccluded 
was randomly assigned to one of four treatment groups: and monastml blue pigment (0.5 to I mllkg) WBE injected into 
Group 1. Verapamil prweafnwzt administrat!on of ve- the coronary vasculature through the left atrium to delineate 
raoamili0.2 mnike bolus iniection. followed bv 0.6 mclke oer the in viva extent of the occluded bed (that is, the in viva 
h hissol& ii siine sol&m and Infused it a rate -of I area at risk).. The heart was arrested by intracardiac injection 
mllmin) initiated 30 min before occiusion and maintained of potassium chloride (20 to 40 mEq) and excised. The 
throughout I5 min of coronary artery occlusion and 180 min positions of the crystals were marked and the heart fixed by 
of rep&&n. This dose of serapamil was chosen because it immersion in It% neutral buffered fcrmrlin 
has been shown to preserve myocardial adenosine triphos- Data anelyais, After fixation, the beans ww cut into six 
phate (ATPI stores in the canine model of the stunned to eight transverse slices, pamllel to the a;rioventriculer 
myocardium (21) and to reduce infarct size in models of groove. each approximately 5 mm thick. Correct placement 
irreversible ischemic injury (14.18.191. of the ultrasonic crystals (in the midn,gocardium, well within 
Grwp 2. “Pnrpunlil 0, rrper~,swn: saline 90l”licm ,I the center of the previously ischemtc and normally perfused 
mlimin) infused for 30 min before occlusion and for the first regionsl was confirmed by gross inspection in all hearts. 
Epacardidl and cndocardial contours of the basal surfaces of variance. pairwise comparisons between groups were made 
the heart tbces. and the margins ofthe occluded left antenor using’fukcy’s test 124). All valw are expressed a~ mean c 
dewendmg coronary ancry bed. wc’c traced onto acctatc standard error of the mean. and were consldered to differ 
shccta. Aftu righ; rco:rico!ar !iwc had hezn trimmed otT, signdicantly If p < 0.05. 
tbe heart slices were weighed. Extent of the area at risk m 
each hear, clicc wac quamificd by compulcrircd planimecry 
and corrected for the weight of the tissue slice (14.lb20L 
Total weight of the area 81 risk we6 calculated for each hean ReS.tJlts 
and expressed as a percent of the total left ventrtcular Mortality (Table I). The distribution of animals random- 
wgh!. ired into each of the four trcatmcnt groups. and the number 
For ,~P<,.~I,~~,,IP,II ,,J no,+,,,, n,wu,r&l blood ,4ow. or deaths, exclusions and survivors in each group are out- 
tissue from both the center of the previously ischemic left lined in Table IA. Of the 48 dogs entered into the protocol. 
anterior descendine coronarv arterv bed and remote. normal 2 were excluded because of hieh collateral blood Row during 
myocardum was cut and &bd&d tnto epicardial, mid- occlusion and a small area at risk. In addition. 21 dogs 
myocardud, and endocardial segments. Regional myocardial succumbed to ventricular fibrillation: 12 between 3 and 14 
blood Row was then quantified by the method of Domenech min after occlusion and the remaining 9 within sexmd~ of 
et al. 031. reperfusion. Thus, a total of 25 dogs successfully completed 
Hr,,,odwmir ,wriahl~r (hmrr ru,r. ,,r/~ri,,l pressure Ihe protocol. 
and d/‘/d!) were measured and averaged over five continu- When verapamil WBE administered before occlusion, the 
ous cardiac cycles for each sample period. In addition, ClPidt incidence of ventricular fibrillation during &hernia or reper- 
was uwd to define the separation of the ultrasonic crystals at fusion was reduced significantly: I of 8 dogs assigned to 
speaftc pants m the cardiac cycle: end-diastolic length was Group I (verapamil pretreatment) developed fibrillation 
defined a\ the enszt of the rapid rise of dP/dt, and end- compared with 20 of 38 dogs in the remaining thres groups 
systolic length was measured at peak negative dP/dt (4,ZO). (excluding those with high collateral Row) @ = 4.29, p < 
End-diactolic and end-systolic length meawrements from 0.05) (Table IB). Vernpamil initiated at rep&&n, how- 
both pairs of cryav& were obtained from three well sepa- 
rated cardlao cycles in each sample period. averaged and 
used to compute segment shortening. defined by convention 
a*: 
Segment shortening values measured in the left anterior 
descending coronary artery bed during each sample period 
were normalized and expressed as a percent of their normal 
barelwe vatties measured bcfurc randomization and treat- 
ment ltha~ ts. percent segment shortening). Values of seg- 
ment shortening measured in the circumflex bed were simi- 
larly normalized and expressed as a percent of their 
respective baseline values. 
Statistics. Dogs with high collateral blood Row during 
coronary occlusion and a small area at risk were excluded 
from the final analysis. Seecificatlv. our exclusion criteria 
were: v&es of r&icnsi myocardial blood Row in the 
“ischemic” endacardium >a.25 mllmin per g tissue during 
coronary artery occlusion. UI an area at risk < IU% of the left 
ever. did not protect against ventricular fibrillation associ- 
ated with reperlusion: 2 of 8 dogs in Group 2 (verapamil at 
reoerfusion) that survived the occlusion develooed fibrilla- 
lidn on reflow, as did 6 of the 18 dogs in Group ~(venpemil 
after reperfusion) and Group 4 (control) (,$ = 0.18. p = NS) 
(Table 10. Thus. vemrardl treatment initiated 30 min 
before coronary artery o&ion protected against ventricu- 
lar fibrillation during either ischemia or reperfusion. 
Area al risk. Area at risk averaged 19 + I%, I9 z 3%. I7 
z 1% and 19 2 2% of the leftventricle in the control. 
verapamil pretreatment, vcrapamil at repcrfusion and yen- 
pamil after reperfusion groups. respectively (p = NS). That 
is. verapamil did not alter area at risk in this model. 
Hemodynamlcs (Table 2). Baseline values of heart rate 
and mean arterial pressure measured before verapamillsaline 
infusion did not vary significantly among the four treatment 
groups. As anticipated, administrdlion of verapamil was 
associated with reduction in both of these hemodynamic 
variables. In dogs pretreated with vcrapamil, mean arterial 
pressure measured both during coronary oalusion and L. 
180 min after reperfusion was significantly less (p < 0.05) 
Yentnclc. ihan iha! in ihe saline conlrol group. Verapamil ad&nistered 
All vanables measured m the study were compared a~ or after reperfusion did not. however. have a statistically 
among !hc txzt:eent groups by analysis of variance. Hemo- signifigant effect on mean arterial pressure. Differences in 
dynamic variables were compared before occlusion, during hean rate among the four treatment groups did not :attain 
corouary occlusion and at the end of the protocol (3 h after statistical significance at any point in the protocol (Table 2). 
rcpcrfuiord. and percent segment shortcmnp in both tissue Peok pmirivr vul~ws ojdPld/ measured before saline or 
regions were compared during occlusion and after 3 h of verapamil infusion were also comparable among the four 
reflow. If sldtistical significance war achieved by analysis of treatment groups (Table 2). No differences in dPidt were 
noted among the four groups. either during coronary ccclu- ?. - I7 t I1 and -21 e b% of preocclusion Y~IUFL for control 
sion or after 3 h of reperfusion. dogr. verapamil pretreatment. verapami! at reperfusion and 
Regional eontrsctite fuactin (Table 3). During coronary verapamil after repcrfwion groups. respectively (p = US) 
occlusion. active contraction in the ischemtc left anterior ITable IA and Fig. I). Thai is. pretreatment with verapamil 
descending ecwmary artery bed was replaced by pas+e did not pleww contractile function during Ihe whemlc 
systolic bulging in all four groups of dogs: percent segment eplrode. 
shortening after 5 min of occlusion averaged - 19 + 7, -8 r In the %dinc control group. contractile function m the 
prcrwsly ischemic myocardium remained depressed or 
“stunned” at30 !o 40% of normal values throughout rcpcr- 
fusion. and averaged +31 t 8% ofpreinfuaion values after 3 
h 01 reflow. In contrast. postischemlc conlraclile dysfunc- 
tion was completely ablated in dogs that had been pretreated 
with verapamd: percem scgmcnt shortening was restored lo 
normal-or supranormal-vaiuec lhroughoul rcpcrfusiun, 
and averaged + I15 q 8% of preocclusion values I the end 
of the protocol Cp < 0.01 versus control wzup). Vcrapamil 
administered at or after reperfusion also attenuated postis- 
chemic contractile dysfunction: values of percent segmenl 
shortening were restored to +66 2 15% and t63 ? 9% of 
normal m Ihe vsrapamil 81 repelfusion and verapamil after 
rcperfusion groups. respectwely. Wllen data from these 
ldtler two groups were pooled. percenl segment shortening 
ar 3 h alter reoerfuslon for this aeereeme mow ,165 t 9%) 
was slg”,ficarily g eater (P i o.os, II%” tie Yalue of t31 * 
8% observed in the saline control croup (Table 3A and 
Fig. I). -’ 
Simdar reuhs uerc obtained when Ihe chrrn#c in percenl 
ae$mcnl shortening between occlusion and 3 h after reper- 
fusiun w, considered for .’ ac ioun groups (Fig. 2). The 
change or rnprovement 1.1 percent segment shortening be- 
wccn occlusion and 180 min after reperfus;on averaged +Sll 
t 6% Inr the sahne conlrcd group. +I23 + 8%, for dogs 
prelrcaled with wspamil tp < 0.01 versus conlroll and +8l 
- 9’L ,p C 0.05 versus control group, and +84 + IO% (p < 
0.05 verw control group) for dogs that received verapamil 
at repe.&usion or after rcperksion. respeclively (Table 3A 
and FIG. 21. Thus. verdpamil adminktered either at or after 
repcfuion rignlficantly enhanced the contratile %nction of 
poslnchemic stunned myocardium, and pretreatment wiih 
verapamil prevcmed poatischemic swnning. 
f+n 0nI rrgmrnl Aorrening in wt~10w wnirrhrmk nyo- 
~ordirrna perfused by the left circumflex artery bed did not 
diBer among the four weatmcnt groups either during ucslu- 
sion or during reperfunion (Table 36). 
High energy phosphale content (Table 4). Adenosine Iri- 
phosphate IATP) cement of normal nonischemic endacar. 
dium averaged 31 to 35 nmolimg cardiac protein and did not 
vary among Ihe four groups. In control dogs, ATP slores 
were depleted by an average of -R.7 + 0.8 nmolimg proteet 
in the previously ischemic rndocardium to 26.5 * I.1 
nmollmp protein at 3 h aflcr reperfusion. Endocardial stores 
of ATP were in part preserved in dogs that had been 
pretreated with verapamil (30.6 + I.2 nmollmg protein. Q C 
0.05 versus control), hut no prwrvation ofendocardial ATP 
intervals throughoul3 h ufreperfusion for each afthe four tr&ent 
groups. V-AT REP = verapamil given al rcperfusion; V-POSTREP 
= vcrapamil given 30 mm after reperfufurion: V-PRE = verapamil 
L!wen before occlurion. ID c 0.0s wrsu Eo”,ml: “P < O.%l “ers”S 
control. 
0% SEGMENT SHORTENING 
,kcchem,c LAD Bed 
content was found in dogs that received verspamil at or after 
reperfusion I25 0 L 1.0 and 27.1 r 1.8 nmolimg protein. 
rcnpectively (p = NS versus controi~ 
In conlrol dogs. ATP stores in Ihe previously lschemlc 
epicardium were only mildly depleled when compared wh 
nurmal nonischemic epardium. Trcatmenr wh verapamil 
did noL result $ rignificant preservat,clon oi sdcnwne tri- 
phosphate stores in this reziion. 
Ckzrine phosphatr m& of ~onnol ~ndrrcrrrdiul ww- 
pies averaged 49.7 i 4.0 nmollmg cardiac prmem m comrol 
dogs. Creatine phosphate “overshoot” wa.s observed I” the 
previously irchernic endocardium of this saline coxroi 
group: values increased by an werage of 9.6 + 4.3 nmalimg 
protein Lo 59.3 2 7.2. Verapsmil admimstered before occlu. 
sion blunted this overshoot in creak phosphate conlem: 
endocardial creatine phosphate confenl was decreased by 
-5.6 + L.9 nmollmg protein bum those observed in normal 
averaged 1.64 2 0.23 mlimin per g (p i 0.05 ver:us cootiol). 
and dogs Waled al or sflcr reflow had mean cndocardial 
flows of 1.11 5 0.34 and 1.12 * II.17 mlimin per g tissue. 
rerpeclivcly (p = NS versus control). Similar results were 
observed after reprrlusiolr in the midmyocardium and epi. 
cardium al’ the previously ix!wmx left anterior descending 
coronxy artery bed arid in all lhiee layers of the nonische- 
m!c circumflex ancry b-d: 11w i,. prclrealment with vera- 
pamd r~gniAcs?tly enhanced regional myocard!al blood Row 
mcarurcd 2 h aflcr reperfusion m both prevmusly iscbemic 
and normally perfused myocardwm. Verapamil edminia- 
wed a1 01 akr reprrfusion did no! hai-c a significant :lkct 
on blood Row in eilhcr ~hc left anlerior descending or the 
wcumRch coronary artery beds. 
EEecis of wrapamil on irrhemir injury. This rtudy dem- 
onstrzlc~ that treatment with verapamd attenuates the phe- 
nomenon of Ihe portkrhemic woned myocardium. Verapa- 
mil. when admmwcred befor< occlusion. was associated 
wilh a rapid uod complc~c recovery of normal contractile 
funrtmn on rcperfusmn and pre~ervalion of high cnercv 
pho,phste slores in rhc prc&usly kchcmic d&e. Ev& 
#hw treatment was “dclaycd” lrha: is. bewn at or after 
nperfui~on). posrlachemlc contractile function of verapamil- 
lrcalcd dog\ was improved wh rcq~ect 10 !he saline-treated 
comroI dogs. Ho q~rovemcnl in high entrgy phosphate 
s,o,c\. however, was observed I” lbesc Ialter two ,rcatmen, 
groups. 
the firrt minutes after coronary oeclu~ion) haa been show 
by mimy mvcsligdlurs WY) 10 favorably modify indexes of 
lwhcnilc Injury llhal IS. reduce ST aegmcnl elevation sod 
infarci bw m m vwo mod45 of regional nchemia followed 
by reperfusion. and in mtidels of permanent coronary artery 
occlusion. Furthermore. as observed in the oresent studv, 
verapamil has been found to exert a protectivf effect against 
the incidence of ventricular fibrillation (U-27), presumably 
due lo an incw-ase in fibrillation threshold (27.28) and re- 
duced conduction delay (29.30) associated with this agent. 
Although the experimental designs differ considerably. these 
data pxallel the obscrvcd protective effect of verapamil 
pretreatment on postischemi~ stunned myocardium. 
F.&cis of wrspamil on regional contra&k fmnctian. Spe- 
cific elfectn of verapamil on regional contractile function. 
however, have yielded conflicting results. Sherman et al. 
(25) found that verapamil. given before occlusion. had no 
elTec1 on se!gnent shortening either during 2 h of &hernia or 
during I h of reperfusion when heart rate was maintained 
constant by pacing. The increase in contractiliry in response 
IO postcx~rasyetolic potcntiation. however. was signiiicandy 
greater in verapamil-treated versus control doss; that is. 
verapamil pretreatment was associated with a greater latent 
capacity for contraction in both ischemic and previously 
lschemic myocardium (25). Smith et al. (31), u&g a par&i 
occlusion model, observed a decrease in contractile function 
of myocardium distal to the site of stenosis after administra- 
tion of venpamil. This led the authors to conclude that 
verapami:. because of its negative inotropic and energy- 
sparing properties, “selectively depressed” the conlractility 
of ischemic myocardium. In contrast. Romson et al. (32) 
found that the eifecis of verapamil varied as a funckx~ of 
myocaruial blovd flow: al nwmal Rows. verapamil had n 
negative inotropic effect. and 81 low flows (30% of normal). 
il had no ctCxl on contractde fun&n. 
Our observation that verapanil. administered before COT- 
onary occlusion, had no effect on segmenl shortening of 
lachemic myocardium measured during coronary arkry oc- 
clusion is in agreemenr with obscrvatiuns made during 
ischemla by Romson et al. (3% and argues against the 
concept of selective depression of whermc myocardium 
raised by Smith et 81. (31). We did oul. holvever. confirm the 
observations of Romson et al. of decreased contractility in 
normally perfused myocardium; verapamd in the presen, 
study had no signilicanl eiTec1 on segment shortening m 
remote nonischemic tissue. 
Further compariaonn bstween our results and lhcce pre- 
vious in viva Etudies arc complicawd by differmce~ m 
experimenral design (that IS. duration oi occlusion and 
degree of &hernia, and Ihercfore the presence of necmhc 
versus reversibly injured myocardiuml. doses of vcrapamd 
and timing of ,rea,ment. Specifically. these prcwous wd!es 
did not f&s on the particular is& of po&chemic myo- 
cardial stunning and the more general question of delayed 
,reatment. Our resubr obtained wth wrap&l preweatmenr 
are. however, in good agreeowN with data oblained usmg 
isolated heart preparations: verapamd pretreatment has been 
shown to improve contractile function after rcoxygena~ion in 
this model (33.34). In cmmas, 10 our present resultr. no 
improvement in postischemic function wa observed when 
verapamil WBB given during the pcrlod of global irchemia ,331 
or hypoxia (34) in these in vitro preparations. 
E&et of verapamil on myoenrdial high energy phosphstr 
stores. Pretrealmrn, with verapamil has cons~s,en,ly been 
shown 10 auenuate the depletion of high energy phosphalc 
stores in models of global ischemia or hypoxia and reperfu- 
sion (33-40). Comparable restdt~ wre firsi obtained in the in 
viva canine model of postischemic stunning by Lange et al. 
(21). and are further confirmed in the present study: that is. 
verapamil prrtrealmenf preserved ATP content of the pre. 
viously ischrmic endow&urn. 
The protectwe cdccr oi vrrapamii on cndocvrdial .4TP 
s,ores was no,, however. observed I” the present rwdy 
when ,rralnxnt was initiated at or after reperfusion Al- 
,hoogh the issue of delayed ~rea,,,,ent haa nat hew ad- 
drewd to dale in previous m viva studies. our resuits are m 
agrcrment with previous I” vitro aork 133.40:: vcrapamil, 
when admmlstcred ailcr ,hc onset ofglobal Ischemia. did not 
aCc, ,hs dcplctmn of ATP m izchcmic or reperfused myo- 
cardmm. 
The fact rhat comracrile fuxtion of Ihe wooed myocar- 
dun uar snhanccd m the v:ra~ilmd :I! reperfusion and 
verapamd dfter rcpcrfwion ~rc’ups wilhoai an incrcasc In 
4TP atore\ reinforces the c&cpl of a dlscockmon belween 
recovery ofcontractile funcnon and recovery of high energy 
phosphate conlcnt observed m prviow studies (20.38). In 
ddiuon. these data provide funher evidence thal the dcplr- 
eon of high energy phosphale slorcs cannot by l&elf fully 
account for contractile dysfunction after a transient brief 
permd of occb~s~on. 
In adrhlmn to ihs protective ctfcc, on endosardial ATP 
s,ores. veraoamil ore,rea,men, also blublcd Ihe ohenomenon . . 
of creatme phasphale overrhoor norm& ass’ooaated with 
oosllachemic ~,wmm~. I?&??). This could be due to ,hc fact 
thal prcwowly ischemic ,issue in doe: preirealcd with 
verapmil was not truly “stunned” as cowactile fuilctmn 
%a( restored ,o baseline values on repelloston. Slorcs of 
creabne phosphate may have been u%d ,n wLam lhis 
normal segment shonening and therefore woold not accu- 
rnula~c (or overshoot) in the previoucly whemic myocar- 
dum (JI). Veapamil administered a, or after reperfusion. 
however. had no effect on crerdine phosphate overshoot in 
rlunncd previously ischemic myocardium. 
Potential meehanismls) of action of verapamii. How can 
the protective and beneficial effects of vcrapamd on wnned 
mj.XdrdlUm be explained? The abdity of verrpamil to 
enhance posrischemic contractde funcrion may be attributed 
to one or more of the specdic or nonspecific consequence? of 
IX calcium channel blocking activity. Specifically. ,he ben- 
cfiaal eRects of vcrapamd adminislcrcd before occlusion 
may be due lo several factors (Table 6). 
I) Swonrr wsoddorhn and reduced arlcnal presrare-.r 
duri,,p orc,uriw 07 during rupcrfurion. In general, UK 
c!Ycclc of aflcrload reduction an regional contractile function 
of stunned myccardium remain somewhat conlroversial: 
some afterload-reducing agents such as nitroglycerin (421. 
enalqril 143) and hydralazine (4.1) were found to enhance 
contmctilc funcdon of previously ischemic myocardium to 
varying degrees. whereas sodium nilroprusside did not exert 
a swificant beneficial effect (43). The improved seamem 
shonening observed in animals that received verapamil 
before occlusion may be due to the agent’s nonspecific 
akriuai-redocizp pxyerdes: !EWWY. beneficial &IS 
have been ohtained using isolaled hearl preparations (X-37) 
d;o/bloodJ?ow during ,epr,f,,rion. Increased &vonar; blood 
Row during reperfusion (produced by infusion of the vase- 
ddalors dipyridamole and papawine) has been associated 
with increased segmenl shortening of stunned pondschemic 
myncardmm (42). It is therefore possible that ihe enhanced 
segmea shortening observed in animals pretreated with 
verapamil was a consequence of coronary varodilation and 
increased oxygen supply LU the stunned myocytes during 
reperfusion 
3111s specific acrion us u rslcism channel blocker on r/w 
myooc)?c~ OS such. Elevated concentrations of inlracellular 
calcium adversely affect both mimchondrial ATP production 
(44) and myocardial contractility (44-46): however. influx of 
intracellular calcium is thought to occur only on rep&&m 
of irrwersrbfy injured myocyle~ (40, 46). It is therefore 
unlikely that verapamil acts on reversibly injured stunned 
myocardium by hlockmg an increase m total tissue calcium 
CO”W”L. 
Although calcium may not accumuhle in reversibly m- 
jured rissue. recent evidence obtained using models of boih 
global (47) and regional ischemia 148) indicates that calcium 
tmn$wt or flux within myocyler is impaired afler brief 
ischemic episodes. This alteration in calcium homeostasis 
may affect mnochondnal fun&n and high energy phos- 
phate producdon. Furthermore. altered calcium flux may 
trigger the production of cytoloxic, oxygen-derived free 
radicals 149). which have been implicated by several inves- 
liQalo:s 120.50.51) in the pathagenesis of postischemic rtun- 
nu~g. Thus. verzpnmd adminisbxed before occlusion may 
also influence poaschemic conlraclile function by favorab& 
modulating calcium borneostasis wthm the m~owtes durine 
toward reduced mean arterial presrure and increased blood 
Row observed in these IWO croups may. taken togclher. be of 
biologic significance to the &&ed t&e. AIte&tively. the 
enhanced regional contractile functim assaciared with late 
treatment Cat or after repetfurion) may he a consequence ol 
favorable alterations in calcium flux at c.r after reperfusion. 
Clearly the precise mechanism or mec%misms of action of 
verapamil oo postischemic stunned myocardium remain to 
he defined. 
Clinical impllcationr. Although any extrapolation ofthese 
experimental data must be made with caution. results of the 
&sent study indicate that verapamil. when administered 
prophylactically, may offer a safe and effective meow of 
trealmenl for the stunned myocardium. Even when treat- 
ment is “delayed”-that IS. inmated ar the rime of rvpe&- 
sioo, or 30 min titer reperiusiun-verapamil exerts a signif- 
icant beneficial effect on contractile function of the 
portischemic stunned myocardium. 

